Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Cappelli

Showing results (121-130 of 196) with videos related to

Pageof 20
Sort By:
European Journal of Heart Failure|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CMMarianna Fontana, Francesco Cappelli, Pablo Garcia-Pavia, et al.
European Journal of Heart Failure|March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CMFrancesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
ESC Heart Failure|July 11, 2024
Eligibility for vericiguat in a real-world, contemporary heart failure populationGiuseppe Vergaro, Alberto Aimo, Francesco Gentile, et al.
JACC. Advances|May 4, 2025
Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac AmyloidosisSara Mori, Noemi Montobbio, Maria Pia Sormani, et al.
International Journal of Cardiology|April 15, 2023
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoringCarlo Fumagalli, Francesca Bonanni, Matteo Beltrami, et al.
ESC Heart Failure|November 27, 2025
Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial DiseasesMarco Merlo, Giulia Bassetto, Antonio Cannatà, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 11, 2024
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseasesMassimo Imazio, Valentino Collini, Alberto Aimo, et al.
European Journal of Preventive Cardiology|August 2, 2023
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathyCarlo Fumagalli, Chiara Zocchi, Francesco Cappelli, et al.
European Journal of Heart Failure|August 3, 2018
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failureChristian Gagliardi, Federico Perfetto, Massimiliano Lorenzini, et al.
Trends in Cardiovascular Medicine|January 14, 2026
Myocarditis and Pericarditis in Focus: A Critical Appraisal of the 2025 ESC vs ACC Position Statements from the Italian Society of Cardiology Working Group on Cardiomyopathies and Pericardial DiseasesMassimo Imazio, Valentino Collini, Marco Merlo, et al.
Pageof 20

Showing results (121-130 of 196) with videos related to

Sort By:
Pageof 20
European Journal of Heart Failure|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CMMarianna Fontana, Francesco Cappelli, Pablo Garcia-Pavia, et al.
European Journal of Heart Failure|March 2, 2026
Impact of acoramidis on clinical stability in transthyretin amyloid cardiomyopathy: Observations from ATTRibute-CMFrancesco Cappelli, Marianna Fontana, Pablo Garcia-Pavia, et al.
ESC Heart Failure|July 11, 2024
Eligibility for vericiguat in a real-world, contemporary heart failure populationGiuseppe Vergaro, Alberto Aimo, Francesco Gentile, et al.
JACC. Advances|May 4, 2025
Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac AmyloidosisSara Mori, Noemi Montobbio, Maria Pia Sormani, et al.
International Journal of Cardiology|April 15, 2023
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoringCarlo Fumagalli, Francesca Bonanni, Matteo Beltrami, et al.
ESC Heart Failure|November 27, 2025
Inflammation and genetics in myo-pericardial diseases: Insights from the Italian Study Group on Cardiomyopathies and Pericardial DiseasesMarco Merlo, Giulia Bassetto, Antonio Cannatà, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 11, 2024
Update on the diagnosis and treatment of pericardial diseases: a position paper of the Italian Society of Cardiology in collaboration with the study group on cardiomyopathies and pericardial diseasesMassimo Imazio, Valentino Collini, Alberto Aimo, et al.
European Journal of Preventive Cardiology|August 2, 2023
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathyCarlo Fumagalli, Chiara Zocchi, Francesco Cappelli, et al.
European Journal of Heart Failure|August 3, 2018
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failureChristian Gagliardi, Federico Perfetto, Massimiliano Lorenzini, et al.
Trends in Cardiovascular Medicine|January 14, 2026
Myocarditis and Pericarditis in Focus: A Critical Appraisal of the 2025 ESC vs ACC Position Statements from the Italian Society of Cardiology Working Group on Cardiomyopathies and Pericardial DiseasesMassimo Imazio, Valentino Collini, Marco Merlo, et al.
Pageof 20